Recent progress in studies on the health benefits of pyrroloquinoline quinone

References

• Goodwin PM, Anthony C. The biochemistry, physiology and genetics of PQQ and PQQ-containing enzymes. Adv. Microb. Physiol. 1998;40:1–80.
   PubMed Web of Science ®Google Scholar
• Anthony C. Pyrroloquinoline quinone (PQQ) and quinoprotein enzymes. Antioxid. Redox Signal. 2001;3:757–774.10.1089/15230860152664966
   PubMed Web of Science ®Google Scholar
• Matsumura H, Umezawa K, Takeda K, et al. Discovery of a eukaryotic pyrroloquinoline quinone-dependent oxidoreductase belonging to a new auxiliary activity family in the database of carbohydrate-active enzymes. PLoS One. 2014;9:e104851. 10.1371/journal.pone.0104851
   PubMed Web of Science ®Google Scholar
• Kumazawa T, Seno H, Urakami T, Matsumoto T, Suzuki O. Trace levels of pyrroloquinoline quinone in human and rat samples detected by gas chromatography/mass spectrometry. Biochim. Biophys. Acta. 1992;1156:62–66. 10.1016/0304-4165(92)90096-D
   PubMed Web of Science ®Google Scholar
• Mitchell AE, Jones AD, Mercer RS, Rucker RB. Characterization of pyrroloquinoline quinone amino acid derivatives by electrospray ionization mass spectrometry and detection in human milk. Anal. Biochem. 1999;269:317–325. 10.1006/abio.1999.4039
   PubMed Web of Science ®Google Scholar
• Kumazawa T, Sato K, Seno H, Ishii A, Suzuki O. Levels of pyrroloquinoline quinone in various foods. Biochem. J. 1995;307:331–333.
   PubMed Web of Science ®Google Scholar
• Kumazawa T, Seno H, Suzuki O. Failure to verify high levels of pyrroloquinoline quinone in eggs and skim milk. Biochem. Biophys. Res. Commun. 1993;193:1–5. 10.1006/bbrc.1993.1581
   PubMed Web of Science ®Google Scholar
• Noji N, Nakamura T, Kitahata N, et al. Simple and sensitive method for pyrroloquinoline quinone (PQQ) analysis in various foods using liquid chromatography/electrospray-ionization tandem mass spectrometry. J. Agric. Food Chem. 2007;55:7258–7263. 10.1021/jf070483r
   PubMed Web of Science ®Google Scholar
• Ghosh S, Chakraborty R, Raychaudhuri U. Pyrroloquinoline quinone a redox cofactor and its involvement in biological system. Int. J. Sci. Nat. 2013;4:371–380.
   Google Scholar
• Choi O, Kim J, Kim JG, et al. Pyrroloquinoline quinone is a plant growth promotion factor produced by Pseudomonas fluorescens B16. Plant Physiol. 2008;146:657–668.
   PubMed Web of Science ®Google Scholar
• Killgore J, Smidt C, Duich L, et al. Nutritional importance of pyrroloquinoline quinone. Science. 1989;245:850–852. 10.1126/science.2549636
   PubMed Web of Science ®Google Scholar
• Steinberg FM, Gershwin ME, Rucker RB. Dietary pyrroloquinoline quinone: growth and immune response in BALB/c mice. J. Nutr. 1994;124:744–753.
   PubMed Web of Science ®Google Scholar
• Steinberg F, Stites T, Anderson P, et al. Pyrroloquinoline quinone improves growth and reproductive performance in mice fed chemically defined diets. Exp. Biol. Med. 2003;228:160–166.
   Web of Science ®Google Scholar
• Kasahara T, Kato T. Nutritional biochemistry: a new redox-cofactor vitamin for mammals. Nature. 2003;422:832.10.1038/422832a
   PubMed Web of Science ®Google Scholar
• Felton LM, Anthony C. Biochemistry: role of PQQ as a mammalian enzyme cofactor? Nature. 2005;433:E10. 10.1038/nature03322
   PubMed Web of Science ®Google Scholar
• Rucker R, Storms D, Sheets A, Tchaparian E, Fascetti A. Biochemistry: is pyrroloquinoline quinone a vitamin? Nature. 2005;433:E10–E11.10.1038/nature03323
   PubMed Web of Science ®Google Scholar
• Paz MA, Martin P, Flückiger R, Mah J, Gallop PM. The catalysis of redox cycling by pyrroloquinoline quinone (PQQ), PQQ derivatives, and isomers and the specificity of inhibitors. Anal. Biochem. 1996;238:145–149. 10.1006/abio.1996.0267
   PubMed Web of Science ®Google Scholar
• Itoh S, Kato N, Ohshiro Y, Agawa T. Catalytic oxidation of thiols by coenzyme PQQ. Chem. Lett. 1985;14:135–136.10.1246/cl.1985.135
   Web of Science ®Google Scholar
• Itoh S, Kato N, Mure M, Ohshiro Y. Kinetic studies on the oxidation of thiols by coenzyme PQQ. Bull. Chem. Soc. Jpn. 1987;60:420–422.10.1246/bcsj.60.420
   Web of Science ®Google Scholar
• Itoh S, Kinugawa M, Mita N, Ohshiro YJ. Efficient NAD+-regeneration system with heteroaromatic o-quinones and molecular oxygen. Chem. Soc. Chem. Commun. 1989;1989:694–695. 10.1039/c39890000694
   Google Scholar
• Itoh S, Ohshiro Y, Agawa T. Reaction of reduced PQQ(PQQH2) and molecular oxygen. Bull. Chem. Soc. Jpn. 1986;59:1911–1914. 10.1246/bcsj.59.1911
   Web of Science ®Google Scholar
• Stites TE, Mitchell AE, Rucker RB. Physiological importance of quinoenzymes and the O-quinone family of cofactors. J Nutr. 2000;130:719–727.
   PubMed Web of Science ®Google Scholar
• Ishii T, Akagawa M, Naito Y, et al. Pro-oxidant action of pyrroloquinoline quinone: characterization of protein oxidative modifications. Biosci. Biotechnol. Biochem. 2010;74:663–666. 10.1271/bbb.90764
   PubMed Web of Science ®Google Scholar
• Shah MA, Bergethon PR, Boak AM, Gallop PM, Kagan HM. Oxidation of peptidyl lysine by copper complexes of pyrroloquinoline quinone and other quinones. A model for oxidative pathochemistry. Biochim. Biophys. Acta. 1992;1159:311–318. 10.1016/0167-4838(92)90061-H
   PubMed Web of Science ®Google Scholar
• Ishida T, Doi M, Tomita K, Hayashi H, Inoue M, Urakami T. Molecular and crystal structure of PQQ (methoxatin), a novel coenzyme of quinoproteins: extensive stacking character and metal ion interaction. J. Am. Chem. Soc. 1989;111:6822–6828. 10.1021/ja00199a050
   Web of Science ®Google Scholar
• Ameyama M, Nonobe M, Shinagawa E, Matsushita K, Adachi O. Method of enzymatic determination of pyrroloquinoline quinone. Anal. Biochem. 1985;151:263–267. 10.1016/0003-2697(85)90174-5
   PubMed Web of Science ®Google Scholar
• Bergethon PR. Amperometric electrochemical detection of pyrroloquinoline quinone in high-performance liquid chromatography. Anal. Biochem. 1990;186:324–327. 10.1016/0003-2697(90)90089-R
   PubMed Web of Science ®Google Scholar
• Harris CB, Chowanadisai W, Mishchuk DO, Satre MA, Slupsky CM, Rucker RB. Dietary pyrroloquinoline quinone (PQQ) alters indicators of inflammation and mitochondrial-related metabolism in human subjects. J. Nutr. Biochem. 2013;24:2076–2084.10.1016/j.jnutbio.2013.07.008
   PubMed Web of Science ®Google Scholar
• Puehringer S, Metlitzky M, Schwarzenbacher R. The pyrroloquinoline quinone biosynthesis pathway revisited: a structural approach. BMC Biochem. 2008;9:8. 10.1186/1471-2091-9-8
   PubMedGoogle Scholar
• Shen YQ, Bonnot F, Imsand EM, RoseFigura JM, Sjölander K, Klinman JP. Distribution and properties of the genes encoding the biosynthesis of the bacterial cofactor, pyrroloquinoline quinone. Biochemistry. 2012;51:2265–2275.10.1021/bi201763d
   PubMed Web of Science ®Google Scholar
• Meulenberg JJ, Sellink E, Loenen WA, Riegman NH, Kleef M, Postma PW. Cloning of Klebsiella pneumoniae pqq genes and PQQ biosynthesis in Escherichia coli. FEMS Microbiol. Lett. 1990;71:337–343. 10.1111/fml.1990.71.issue-3
   Web of Science ®Google Scholar
• Klinman JP, Bonnot F. Intrigues and intricacies of the biosynthetic pathways for the enzymatic quinocofactors: PQQ, TTQ, CTQ, TPQ, and LTQ. Chem. Rev. 2014;114:4343–4365.10.1021/cr400475g
   PubMed Web of Science ®Google Scholar
• Velterop JS, Sellink E, Meulenberg JJ, David S, Bulder I, Postma PW. Synthesis of pyrroloquinoline quinone in vivo and in vitro and detection of an intermediate in the biosynthetic pathway. J. Bacteriol. 1995;177:5088–5098.
   PubMed Web of Science ®Google Scholar
• Bonnot F, Iavarone AT, Klinman JP. Multistep, eight-electron oxidation catalyzed by the cofactorless oxidase, pqqc: identification of chemical intermediates and their dependence on molecular oxygen. Biochemistry. 2013;52:4667–4675. 10.1021/bi4003315
   PubMed Web of Science ®Google Scholar
• Magnusson OT, Toyama H, Saeki M, et al. Quinone biogenesis: Structure and mechanism of PqqC, the final catalyst in the production of pyrroloquinoline quinone. Proc. Natl. Acad. Sci. USA. 2004;101:7913–7918.10.1073/pnas.0402640101
   PubMed Web of Science ®Google Scholar
• van Kleef MA, Duine JA. Factors relevant in bacterial pyrroloquinoline quinone production. Appl. Environ. Microbiol. 1989;55:1209–1213.
   PubMed Web of Science ®Google Scholar
• Smidt CR, Bean-Knudsen D, Kirsch DG, Rucker RB. Does the intestinal microflora synthesize pyrroloquinoline quinone? Biofactors. 1991;3:53–59.
   PubMed Web of Science ®Google Scholar
• Matsushita K, Arents JC, Bader R, Yamada M, Adachi O, Postma PW. Escherichia coli is unable to produce pyrroloquinoline quinone (PQQ). Microbiology. 1997;143:3149–3156.10.1099/00221287-143-10-3149
   PubMed Web of Science ®Google Scholar
• Samuel KG, Zhang HJ, Wang J, et al. Effects of dietary pyrroloquinoline quinone disodium on growth performance, carcass yield and antioxidant status of broiler chicks. Animal. 2015;9:409–416. 10.1017/S1751731114002328
   PubMed Web of Science ®Google Scholar
• Naito Y, Kumazawa T, Kino I, Suzuki O. Effects of pyrroloquinoline quinone (PQQ) and PQQ-oxazole on DNA synthesis of cultured human fibroblasts. Life Sci. 1993;52:1909–1915.10.1016/0024-3205(93)90631-C
   PubMed Web of Science ®Google Scholar
• Kumazawa T, Hiwasa T, Takiguchi M, Suzuki O, Sato K. Activation of Ras signaling pathways by pyrroloquinoline quinone in NIH3T3 mouse fibroblasts. Int. J. Mol. Med. 2007;19:765–770.
   PubMed Web of Science ®Google Scholar
• Kimura K, Takada M, Ishii T, Tsuji-Naito K, Akagawa M. Pyrroloquinoline quinone stimulates epithelial cell proliferation by activating epidermal growth factor receptor through redox cycling. Free Radic. Biol. Med. 2012;53:1239–1251.10.1016/j.freeradbiomed.2012.07.015
   PubMed Web of Science ®Google Scholar
• McKay MM, Morrison DK. Integrating signals from RTKs to ERK/MAPK. Oncogene. 2007;26:3113–3121. 10.1038/sj.onc.1210394
   PubMed Web of Science ®Google Scholar
• Lee SR, Kwon KS, Kim SR, Rhee SG. Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor. J. Biol. Chem. 1998;273:15366–15372. 10.1074/jbc.273.25.15366
   PubMed Web of Science ®Google Scholar
• Iwamoto N, Sumi D, Ishii T, et al. Chemical knockdown of protein-tyrosine phosphatase 1B by 1,2-naphthoquinone through covalent modification causes persistent transactivation of epidermal growth factor receptor. J. Biol. Chem. 2007;282:33396–33404. 10.1074/jbc.M705224200
   PubMed Web of Science ®Google Scholar
• Chiarugi P, Cirri P. Redox regulation of protein tyrosine phosphatases during receptor tyrosine kinase signal transduction. Trends Biochem. Sci. 2003;28:509–514. 10.1016/S0968-0004(03)00174-9
   PubMed Web of Science ®Google Scholar
• Kenner KA, Anyanwu E, Olefsky JM, Kusari J. Protein-tyrosine phosphatase 1B is a negative regulator of insulin- and insulin-like growth factor-i-stimulated signaling. J. Biol. Chem. 1996;271:19810–19816. 10.1074/jbc.271.33.19810
   PubMed Web of Science ®Google Scholar
• Chang Y, Ceacareanu B, Zhuang D, et al. Arterioscler. Counter-regulatory function of protein tyrosine phosphatase 1B in platelet-derived growth factor- or fibroblast growth factor-induced motility and proliferation of cultured smooth muscle cells and in neointima formation. Thromb. Vasc. Biol. 2006;26:501–507.
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Patrushev N, Inomata H, et al. Role of protein tyrosine phosphatase 1B in vascular endothelial growth factor signaling and cell-cell adhesions in endothelial cells. Circ. Res. 2008;102:1182–1191.10.1161/CIRCRESAHA.107.167080
   PubMed Web of Science ®Google Scholar
• Shibata T, Nakahara H, Kita N, et al. A food-derived synergist of NGF signaling: identification of protein tyrosine phosphatase 1B as a key regulator of NGF receptor-initiated signal transduction. J. Neurochem. 2008;107:1248–1260.10.1111/jnc.2008.107.issue-5
   PubMed Web of Science ®Google Scholar
• Garber AJ. Obesity and type 2 diabetes: which patients are at risk? Diabetes Obes. Metab. 2012;14:399–408.10.1111/dom.2012.14.issue-5
   PubMed Web of Science ®Google Scholar
• Saltiel AR. New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell. 2001;104:517–529.10.1016/S0092-8674(01)00239-2
   PubMed Web of Science ®Google Scholar
• van Tienen FH, Praet SF, de Feyter HM, et al. Physical activity is the key determinant of skeletal muscle mitochondrial function in type 2 diabetes. J. Clin. Endocrinol. Metab. 2012;97:3261–3269.10.1210/jc.2011-3454
   PubMed Web of Science ®Google Scholar
• Rabøl R, Boushel R, Dela F. Mitochondrial oxidative function and type 2 diabetes. Appl. Physiol. Nutr. Metab. 2006;31:675–683.10.1139/h06-071
   PubMed Web of Science ®Google Scholar
• Meex RC, Schrauwen-Hinderling VB, Moonen-Kornips E, et al. Restoration of muscle mitochondrial function and metabolic flexibility in type 2 diabetes by exercise training is paralleled by increased myocellular fat storage and improved insulin sensitivity. Diabetes. 2010;59:572–579.10.2337/db09-1322
   PubMed Web of Science ®Google Scholar
• Stites T, Storms D, Bauerly K, et al. Pyrroloquinoline quinone modulates mitochondrial quantity and function in mice. J. Nutr. 2006;136:390–396.
   PubMed Web of Science ®Google Scholar
• Bauerly K, Harris C, Chowanadisai W, et al. Altering pyrroloquinoline quinone nutritional status modulates mitochondrial, lipid, and energy metabolism in rats. PLoS One. 2011;6:e21779.10.1371/journal.pone.0021779
   PubMed Web of Science ®Google Scholar
• Tao R, Karliner JS, Simonis U, et al. Pyrroloquinoline quinone preserves mitochondrial function and prevents oxidative injury in adult rat cardiac myocytes. Biochem. Biophys. Res. Commun. 2007;363:257–262. 10.1016/j.bbrc.2007.08.041
   PubMed Web of Science ®Google Scholar
• Handschin C, Spiegelman BM. Peroxisome proliferator-activated receptor γ coactivator 1 coactivators, energy homeostasis, and metabolism. Endocr. Rev. 2006;27:728–735. 10.1210/er.2006-0037
   PubMed Web of Science ®Google Scholar
• Feige JN, Auwerx J. Transcriptional coregulators in the control of energy homeostasis. Trends Cell Biol. 2007;17:292–301. 10.1016/j.tcb.2007.04.001
   PubMed Web of Science ®Google Scholar
• Chowanadisai W, Bauerly KA, Tchaparian E, Wong A, Cortopassi GA, Rucker RB. Pyrroloquinoline quinone stimulates mitochondrial biogenesis through cAMP response element-binding protein phosphorylation and increased PGC-1α expression. J Biol Chem. 2010;285:142–152. 10.1074/jbc.M109.030130
   PubMed Web of Science ®Google Scholar
• Byon JC, Kusari AB, Kusari J. Protein-tyrosine phosphatase-1B acts as a negative regulator of insulin signal transduction. Mol. Cell. Biochem. 1998;182:101–108. 10.1023/A:1006868409841
   PubMed Web of Science ®Google Scholar
• Ahmad F, Azevedo JL, Cortright R, Dohm GL, Goldstein BJ. Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes. J. Clin. Invest. 1997;100:449–458. 10.1172/JCI119552
   PubMed Web of Science ®Google Scholar
• Cheung A1, Kusari J, Jansen D, Bandyopadhyay D, Kusari A, Bryer-Ash M. Marked impairment of protein tyrosine phosphatase 1B activity in adipose tissue of obese subjects with and without type 2 diabetes mellitus. J. Lab. Clin. Med. 1999;134:115–123.10.1016/S0022-2143(99)90115-4
   PubMed Web of Science ®Google Scholar
• Cheung A1, Kusari J, Jansen D, Bandyopadhyay D, Kusari A, Bryer-Ash M. Marked impairment of protein tyrosine phosphatase 1B activity in adipose tissue of obese subjects with and without type 2 diabetes mellitus. Diabetes. 2012;61:1415–1422.
   PubMed Web of Science ®Google Scholar
• Zabolotny JM, Haj FG, Kim YB, et al. Transgenic overexpression of protein-tyrosine phosphatase 1B in muscle causes insulin resistance, but overexpression with leukocyte antigen-related phosphatase does not additively impair insulin action. J. Biol. Chem. 2004;279:24844–24851.10.1074/jbc.M310688200
   PubMed Web of Science ®Google Scholar
• Klaman LD, Boss O, Peroni OD, et al. Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol. Cell Biol. 2000;20:5479–5489. 10.1128/MCB.20.15.5479-5489.2000
   PubMed Web of Science ®Google Scholar
• Zinker BA, Rondinone CM, Trevillyan JM, et al. PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice. Proc. Natl. Acad. Sci. USA. 2002;99:11357–11362. 10.1073/pnas.142298199
   PubMed Web of Science ®Google Scholar
• Popov D. Novel protein tyrosine phosphatase 1B inhibitors: interaction requirements for improved intracellular efficacy in type 2 diabetes mellitus and obesity control. Biochem. Biophys. Res. Commun. 2011;410:377–381. 10.1016/j.bbrc.2011.06.009
   PubMed Web of Science ®Google Scholar
• Takada M, Sumi M, Maeda A, et al. Pyrroloquinoline quinone, a novel protein tyrosine phosphatase 1B inhibitor, activates insulin signaling in C2C12 myotubes and improves impaired glucose tolerance in diabetic KK-Ay mice. Biochemn. Biophys. Res. Commun. 2012;428:315–320. 10.1016/j.bbrc.2012.10.055
   PubMed Web of Science ®Google Scholar
• Miyauchi K, Urakami T, Abeta H, Shi H, Noguchi N, Niki E. Action of pyrroloquinolinequinol as an antioxidant against lipid peroxidation in solution. Antiox. Redox. Signal. 1994;1:547–554.
   Web of Science ®Google Scholar
• He K, Nukada H, Urakami T, Murphy MP. Antioxidant and pro-oxidant properties of pyrroloquinoline quinone (PQQ): implications for its function in biological systems. Biochem. Pharmacol. 2003;65:67–74.10.1016/S0006-2952(02)01453-3
   PubMed Web of Science ®Google Scholar
• Ouchi A, Nakano M, Nagaoka S, Mukai K. Kinetic study of the antioxidant activity of pyrroloquinolinequinol (PQQH2, a reduced form of pyrroloquinolinequinone) in micellar solution. J. Agric. Food Chem. 2009;57:450–456.10.1021/jf802197d
   PubMed Web of Science ®Google Scholar
• Mukai K, Ouchi A, Nakano M. Kinetic study of the quenching reaction of singlet oxygen by pyrroloquinolinequinol (PQQH2, a reduced form of pyrroloquinolinequinone) in micellar solution. J. Agri. Food Chem. 2011;59:1705–1712.10.1021/jf104420y
   PubMed Web of Science ®Google Scholar
• Ouchi A, Ikemoto K, Nakano M, Nagaoka S, Mukai K. Kinetic study of aroxyl radical scavenging and α-tocopheroxyl regeneration rates of pyrroloquinolinequinol (PQQH2, a reduced form of pyrroloquinolinequinone) in dimethyl sulfoxide solution: finding of synergistic effect on the reaction rate due to the coexistence of α-tocopherol and PQQH2. J. Agric. Food Chem. 2013;61:11048–11060. 10.1021/jf4040496
   PubMed Web of Science ®Google Scholar
• Hara H, Hiramatsu H, Adachi T. Pyrroloquinoline quinone is a potent neuroprotective nutrient against 6-hydroxydopamine-induced neurotoxicity. Neurochem. Res. 2007;32:489–495.10.1007/s11064-006-9257-x
   PubMed Web of Science ®Google Scholar
• Nunome K, Miyazaki S, Nakano M, Iguchi-Ariga S, Ariga H. Pyrroloquinoline quinone prevents oxidative stress-induced neuronal death probably through changes in oxidative status of DJ-1. Biol. Pharm. Bull. 2008;31:1321–1326. 10.1248/bpb.31.1321
   PubMed Web of Science ®Google Scholar
• Zhu B, Zhou H, Teerlink JR, Karliner JS. Pyrroloquinoline quinone (PQQ) decreases myocardial infarct size and improves cardiac function in rat models of ischemia and ischemia/reperfusion. Cardiovasc. Drugs. Ther. 2004;18:421–431. 10.1007/s10557-004-6219-x
   PubMed Web of Science ®Google Scholar
• Zhu B, Simonis U, Cecchini G, et al. Comparison of pyrroloquinoline quinone and/or metoprolol on myocardial infarct size and mitochondrial damage in a rat model of ischemia/reperfusion injury. J. Cardiovasc. Pharm. Ther. 2006;11:119–128.10.1177/1074248406288757
   PubMed Web of Science ®Google Scholar
• Jensen FE, Gardner GJ, Williams AP, Gallop PM, Aizenman E, Rosenberg PA. The putative essential nutrient pyrroloquinoline quinone is neuroprotective in a rodent model of hypoxic/ischemic brain injury. Neuroscience. 1994;62:399–406. 10.1016/0306-4522(94)90375-1
   PubMed Web of Science ®Google Scholar
• Zhang Y, Feustel P, Kimelberg HK. Neuroprotection by pyrroloquinoline quinone (PQQ) in reversible middle cerebral artery occlusion in the adult rat. Brain Res. 2006;1094:200–206. 10.1016/j.brainres.2006.03.111
   PubMed Web of Science ®Google Scholar
• Yamaguchi K, Sasano A, Urakami T, Tsuji T, Kondo K. Stimulation of nerve growth factor production by pyrroloquinoline quinone and its derivatives in vitro and in vivo. Biosci. Biotech. Biochem. 1993;57:1231–1233. 10.1271/bbb.57.1231
   PubMed Web of Science ®Google Scholar
• Murase K, Hattori A, Kohno M, Hayashi K. Stimulation of nerve growth factor synthesis/secretion in mouse astroglial cells by coenzymes. Biochem. Mol. Biol. Internat. 1993;30:615–621.
   PubMedGoogle Scholar
• Yamaguchi K, Tsuji T, Uemura D, Kondo K. Cyclooxygenase induction is essential for NGF synthesis enhancement by NGF inducers in L-M cells. Biosci. Biotech. Biochem. 1996;60:92–94.10.1271/bbb.60.92
   PubMed Web of Science ®Google Scholar
• Ohwada K, Takeda H, Yamazaki M, et al. Pyrroloquinoline quinone (PQQ) prevents cognitive deficit caused by oxidative stress in rats. J. Clin. Biochem. Nutr. 2008;42:29–34.10.3164/jcbn.2008005
   PubMed Web of Science ®Google Scholar
• Takatsu H, Owada K, Abe K, Nakano M, Urano S. Effect of Vitamin E on learning and memory deficit in aged rats. J. Nutr. Sci. Vitaminol. 2009;55:389–393.10.3177/jnsv.55.389
   PubMed Web of Science ®Google Scholar
• Koikeda T, Nakano M, Masuda K. Pyrroloquinoline quinone disodium salt improves higher brain function. Med. Consult. New Remedies. 2011;48:519–527.
   Google Scholar
• Randolph C, Tierney MC, Mohr E, Chase TN. The repeatable battery for the assessment of neuropsychological status (RBANS): preliminary clinical validity. J. Clin. Exp. Neuropsychol. 1989;20:310–319.
   Web of Science ®Google Scholar
• Itoh Y, Hine K, Miura H, et al. Effect of the antioxidant supplement pyrroloquinoline quinone disodium salt (BioPQQ™) on cognitive functions. Adv. Exp. Med. Biol. in press
   Google Scholar
• Hakoda Y, Sasaki M. Group version of the stroop and reverse-stroop test–the effects of reaction mode, order and practice–jap. J. Educational Psychol. 1990;38:389–394 (in Japanese).
   Google Scholar
• Hayashi Y, Kijima T, Satou K, Murakami S. Examination of the evaluation method of visual-spatial cognitive function using the touch screen device. Jap. J. Geria. Psychiatry. 2011;22:439–447 (in Japanese).
   Google Scholar
• Nakano M, Yamamoto T, Okumura H, Tsuda A, Kowatari Y. Effects of oral supplementation with pyrroloquinoline quinone on stress, fatigue, and sleep. Funct. Foods Health Dis. 2012;2:307–324.
   Google Scholar
• Nakano M, Kamimura A, Watanabe F, et al. Effects of orally administered pyrroloquinoline quinone disodium salt on dry skin conditions in mice and healthy female subjects. J. Nutr. Sci. Vitaminol. 2015;61:242–247.
   Web of Science ®Google Scholar
• Nakano M, Kawasaki Y, Suzuki N, Takara T. Effects of pyrroloquinoline quinone disodium salt intake on the serum cholesterol levels of healthy Japanese adults. J. Nutr. Sci. Vitaminol. 2015;61:234–241.
   Web of Science ®Google Scholar
• Nakano M, Takahashi H, Koura S, Chung C, Tafazoli S, Roberts A. Acute and subchronic toxicity studies of pyrroloquinoline quinone (PQQ) disodium salt (BioPQQ™) in rats. Regul. Toxicol. Pharmacol. 2014;70:107–121. 10.1016/j.yrtph.2014.06.024
   PubMed Web of Science ®Google Scholar
• Liang C, Zhang X, Wang W, Song Y, Jia X. A subchronic oral toxicity study on pyrroloquinoline quinone (PQQ) disodium salt in rats. Food Chem. Toxicol. 2015;75:146–150.10.1016/j.fct.2014.11.005
   PubMed Web of Science ®Google Scholar
• Nakano M, Suzuki H, Imamura T, Lau A, Lynch B. Genotoxicity of pyrroloquinoline quinone (PQQ) disodium salt (BioPQQ™). Regul. Toxicol. Pharmacol. 2013;67:189–197.10.1016/j.yrtph.2013.07.007
   PubMed Web of Science ®Google Scholar
• Rucker R, Chowanadisai E, Nakano M. Potential physiological importance of pyrroloquinoline quinone. Altern. Med. Res. 2009;14:268–277.
   PubMed Web of Science ®Google Scholar
• Smidt CR, Unkefer CJ, Houck DR, Rucker RB. Intestinal absorption and tissue distribution of [14C]pyrroloquinoline Quinone in mice. Proc. Soc. Exp. Biol. Med. 1991;197:27–31.10.3181/00379727-197-43219
   PubMed Web of Science ®Google Scholar
• Watanabe A, Hobara N, Ohsawa T, Higashi T, Tsuji T. Nephrotoxicity of pyrroloquinoline quinone in rats. Hiroshima J. Med. Sci. 1989;38:49–51.
   PubMedGoogle Scholar